Atherosclerotic Cardiovascular Diseases Unknown Status Phase 2 Trials for Evolocumab (DB09303)

Back to Atherosclerotic Cardiovascular Diseases

Also known as: Atherosclerotic Cardiovascular Disease / Atheromatosis / Atherosclerotic heart disease of native coronary artery / Atherosclerosis / Atherosclerosis (morphologic abnormality) / Arteriosclerotic vascular disease (disorder) / Arteriosclerosis / Arteriosclerosis (morphologic abnormality) / Vascular sclerosis (morphologic abnormality)

Indication	Status	Phase
DBCOND0078488 (Atherosclerotic Cardiovascular Diseases)	Unknown Status	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04338165	Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography	Treatment	Evolocumab (DB09303)